About us

Clinical research, with dynamism and quality.
Essential factor for the development of new drugs.

The clinical researches in Brazil move forward due to our researchers' talent, quality, excellence and dedication, internationally projecting the clinical studies accomplished here.

In this context, Scentryphar develops and implements bioequivalence and bioavailability studies in Brazil and abroad, always acting in an agile and effective way. Constituted by pioneer doctors and masters in Brazil and with wide experience in the conduction of clinical pharmacology studies of phases I through IV, our company stands out for its commitment to the quality of the researches and services developed.